IGM Biosciences Inc (NASDAQ: IGMS) is -70.95% lower on its value in year-to-date trading and has touched a low of $1.87 and a high of $22.50 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IGMS stock was last observed hovering at around $2.09 in the last trading session, with the day’s loss setting it -0.32%.
Currently trading at $1.77, the stock is -71.72% and -81.14% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.58 million and changing -15.07% at the moment leaves the stock -82.73% off its SMA200. IGMS registered -83.96% loss for a year compared to 6-month loss of -81.59%. The firm has a 50-day simple moving average (SMA 50) of $9.7197 and a 200-day simple moving average (SMA200) of $10.3126.
The stock witnessed a -81.30% gain in the last 1 month and extending the period to 3 months gives it a -87.22%, and is -72.94% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.86% over the week and 11.23% over the month.
IGM Biosciences Inc (IGMS) has around 224 employees, a market worth around $105.55M and $2.92M in sales. Profit margin for the company is -7534.03%. Distance from 52-week low is -5.08% and -92.11% from its 52-week high. The company has generated returns on investments over the last 12 months (-186.14%).
with sales reaching $366.67k over the same period.The EPS is expected to grow by 32.32% this year, but quarterly earnings will post 23.34% year-over-year. Quarterly sales are estimated to shrink -43.68% in year-over-year returns.
IGM Biosciences Inc (IGMS) Top Institutional Holders
120.0 institutions hold shares in IGM Biosciences Inc (IGMS), with institutional investors hold 98.42% of the company’s shares. The shares outstanding are 34.06M, and float is at 17.58M with Short Float at 14.29%. Institutions hold 64.03% of the Float.
The top institutional shareholder in the company is BAKER BROS. ADVISORS LP with over 4.09 million shares valued at $28.1 million. The investor’s holdings represent 6.8042% of the IGMS Shares outstanding. As of 2024-06-30, the second largest holder is PRICE T ROWE ASSOCIATES INC /MD/ with 4.08 million shares valued at $28.0 million to account for 6.7789 of the shares outstanding. The other top investors are ARTAL GROUP S.A. which holds 3.33 million shares representing 5.5401% and valued at over $22.88 million, while REDMILE GROUP, LLC holds 5.1111 of the shares totaling 3.07 million with a market value of $21.11 million.
IGM Biosciences Inc (IGMS) Insider Activity
The most recent transaction is an insider sale by Weber Steven, the company’s PRINCIPAL ACCOUNTING OFFICER. SEC filings show that Weber Steven sold 539 shares of the company’s common stock on Dec 16 ’24 at a price of $7.48 per share for a total of $4032.0. Following the sale, the insider now owns 31704.0 shares.
IGM Biosciences Inc disclosed in a document filed with the SEC on Dec 16 ’24 that Decker Lisa Lynn (CHIEF BUSINESS OFFICER) sold a total of 1,063 shares of the company’s common stock. The trade occurred on Dec 16 ’24 and was made at $7.48 per share for $7951.0. Following the transaction, the insider now directly holds 78041.0 shares of the IGMS stock.
Still, SEC filings show that on Dec 16 ’24, Harler Mary Beth (Chief Executive Officer) disposed off 1,708 shares at an average price of $7.48 for $12776.0. The insider now directly holds 347,032 shares of IGM Biosciences Inc (IGMS).
